Total Payments
$936.53
2024 Payments
$43.70
Companies
8
Transactions
22
Medicare Patients
954
Medicare Billing
$108,225
Payment Breakdown by Category
Food & Beverage$936.53 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $936.53 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $393.95 | 5 | $0 (2021) |
| Lilly USA, LLC | $130.62 | 8 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $125.00 | 1 | $0 (2018) |
| Boston Scientific Corporation | $100.16 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $78.29 | 1 | $0 (2017) |
| Novo Nordisk Inc | $73.55 | 4 | $0 (2024) |
| ViiV Healthcare Company | $22.25 | 1 | $0 (2024) |
| Horizon Therapeutics plc | $12.71 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.70 | 2 | ViiV Healthcare Company ($22.25) |
| 2023 | $17.81 | 1 | Novo Nordisk Inc ($17.81) |
| 2022 | $34.29 | 2 | Novo Nordisk Inc ($34.29) |
| 2021 | $190.85 | 5 | AstraZeneca Pharmaceuticals LP ($124.59) |
| 2020 | $117.39 | 7 | Lilly USA, LLC ($64.36) |
| 2019 | $215.29 | 2 | AstraZeneca Pharmaceuticals LP ($115.13) |
| 2018 | $125.00 | 1 | SANOFI-AVENTIS U.S. LLC ($125.00) |
| 2017 | $192.20 | 2 | AstraZeneca Pharmaceuticals LP ($113.91) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $22.25 | General |
| 01/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Diabetes | ||||||
| 01/31/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 11/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Diabetes | ||||||
| 03/09/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Diabetes | ||||||
| 11/16/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Neuroscience | ||||||
| 07/07/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/30/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Neuroscience | ||||||
| 04/28/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Neuroscience | ||||||
| 03/04/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Neuroscience | ||||||
| 10/22/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Neuroscience | ||||||
| 09/04/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Neuroscience | ||||||
| 07/21/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Neuroscience | ||||||
| 07/14/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/18/2020 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: RAYOS | ||||||
| 02/25/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Neuroscience | ||||||
| 09/24/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $115.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/11/2019 | Boston Scientific Corporation | OBTRYX (Device) | Food and Beverage | In-kind items and services | $100.16 | General |
| Category: PELVIC ORGAN PROLAPSE | ||||||
| 04/09/2018 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 10/12/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $113.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2017 | Merck Sharp & Dohme Corporation | JANUMET (Drug) | Food and Beverage | In-kind items and services | $78.29 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 170 | 177 | $194,644 | $14,938 |
| 2022 | 3 | 101 | 103 | $92,096 | $10,744 |
| 2021 | 5 | 270 | 275 | $212,365 | $32,145 |
| 2020 | 4 | 413 | 416 | $317,096 | $50,397 |
Total Patients
954
Total Services
971
Medicare Billing
$108,225
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 53 | 53 | $85,277 | $6,615 | 7.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 27 | 27 | $54,243 | $4,222 | 7.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 44 | 45 | $50,232 | $3,801 | 7.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 46 | 52 | $4,892 | $299.88 | 6.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 37 | 38 | $46,136 | $5,711 | 12.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 49 | 50 | $38,120 | $4,365 | 11.5% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 15 | 15 | $7,840 | $668.58 | 8.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 116 | 118 | $110,946 | $16,954 | 15.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 79 | 82 | $50,192 | $7,589 | 15.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 31 | 31 | $36,624 | $6,194 | 16.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 31 | 31 | $12,778 | $1,325 | 10.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 13 | 13 | $1,825 | $83.33 | 4.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 206 | 207 | $171,603 | $28,082 | 16.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 56 | 56 | $66,584 | $11,206 | 16.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 118 | 120 | $66,600 | $9,559 | 14.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 33 | 33 | $12,309 | $1,550 | 12.6% |
About Dr. Michael Ward, M.D
Dr. Michael Ward, M.D is a Emergency Medicine healthcare provider based in Waupaca, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2010. The National Provider Identifier (NPI) number assigned to this provider is 1316279433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ward, M.D has received a total of $936.53 in payments from pharmaceutical and medical device companies, with $43.70 received in 2024. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($936.53).
As a Medicare-enrolled provider, Ward has provided services to 954 Medicare beneficiaries, totaling 971 services with total Medicare billing of $108,225. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine, Emergency Medicine
- Location Waupaca, WI
- Active Since 02/01/2010
- Last Updated 09/12/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1316279433
Products in Payments
- FARXIGA (Drug) $393.95
- EMGALITY (Drug) $130.62
- SYNVISC-ONE (Device) $125.00
- OBTRYX (Device) $100.16
- JANUMET (Drug) $78.29
- Ozempic (Drug) $39.26
- Rybelsus (Drug) $34.29
- RAYOS (Drug) $12.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Waupaca
Dr. Christina Nussbaum, M.d, M.D
Emergency Medicine — Payments: $821.77
Emergency Medicine $821.77
Robin Purdy, D.o, D.O
Emergency Medicine — Payments: $186.72
Emergency Medicine $186.72
Dr. Spencer Greaves, Md, MD
Emergency Medicine — Payments: $137.38
Emergency Medicine $137.38
Isaac Troiano, Do, DO
Emergency Medicine — Payments: $124.57
Emergency Medicine $124.57
Magdy Eskander
Emergency Medicine — Payments: $64.93
Emergency Medicine $64.93
Dr. Matthew Nelson, D.o, D.O
Emergency Medicine — Payments: $15.16
Emergency Medicine $15.16